Nanomaterials for radiotherapeutics-based multimodal synergistic cancer therapy

Over the past decade, numerous studies have attempted to enhance the effectiveness of radiotherapy (external beam radiotherapy and internal radioisotope therapy) for cancer treatment. However, the low radiation absorption coefficient and radiation resistance of tumors remain major critical challenges for radiotherapy in the clinic. With the development of nanomedicine, nanomaterials in combination with radiotherapy offer the possibility to improve the efficiency of radiotherapy in tumors. Nanomaterials act not only as radiosensitizers to enhance radiation energy, but also as nanocarriers to deliver therapeutic units in combating radiation resistance. In this review, we discuss opportunities for a synergistic cancer therapy by combining radiotherapy based on nanomaterials designed for chemotherapy, photodynamic therapy, photothermal therapy, gas therapy, genetic therapy, and immunotherapy. We highlight how nanomaterials can be utilized to amplify antitumor radiation responses and describe cooperative enhancement interactions among these synergistic therapies. Moreover, the potential challenges and future prospects of radio-based nanomedicine to maximize their synergistic efficiency for cancer treatment are identified.

     

APOBEC 家族的功能研究进展

APOBEC是人体内具有胞嘧啶脱氨酶活性的家族，共11个成员，是人体的天然防御者。 APOBEC通过与DNA和RNA结合，使底物上的胞嘧啶C脱氨基，可完成其各自不同的功能。 APOBEC1编辑载脂蛋白B的mRNA，AID在抗体成熟中的体细胞超突变和类别转换重组中起关键作用，APOBEC3可抑制反转录病毒复制，而APOBEC2和APOBEC4的功能还不完全清楚。采用文献综述法，比较分析近年来国内外关于APOBEC家族各成员的结构和功能研究的新进展，为进一步研究APOBEC家族的抗病毒功能和艾滋病等疾病的治疗提供参考。